The role of Allee effect in modelling post resection recurrence of glioblastoma.

by Zoltan Neufeld, William von Witt, Dora Lakatos, Jiaming Wang, Balazs Hegedus, Andras Czirok
Published 2017-11-01

Primary Human Fibroblasts in Culture Switch to a Myofibroblast-Like Phenotype Independently of TGF Beta

by Ulrike Baranyi, Birgitta Winter, Alfred Gugerell, Balazs Hegedus, Christine Brostjan, Günther Laufer, Barbara Messner
Published 2019-07-01

Characterization of human pituitary adenomas in cell cultures by light and electron microscopic morphology and immunolabeling

by Emil Pásztor, Katalin Bálint, Feliícia Slowik, Edit Kerekes, Ernő Bácsy, Balázs Hegedűs, Ilona Fazekas
Published 2011-08-01

Dataset of a study investigating autologous blood patch pleurodesis in postoperative prolonged air leaks after lung resection

by Till Ploenes, Ioanis Kyritsis, Sandra Kampe, Khaled Mardanzai, Linda Langehegermann, Alexis Slama, Balazs Hegedüs, Clemens Aigner
Published 2020-08-01

Insights into immunometabolism: A dataset correlating the 18FDG PET/CT maximum standard uptake value of the primary tumor with the CCL18 serum level in non-small cell lung cancer

by Tugba Dönmez, Kerstin Höhne, Gernot Zissel, Ken Herrmann, Hubertus Hautzel, Clemens Aigner, Balazs Hegedüs, Till Ploenes
Published 2021-04-01

From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC).

by Zoltan Lohinai, Peter Dome, Zsuzsa Szilagyi, Gyula Ostoros, Judit Moldvay, Balazs Hegedus, Balazs Dome, Glen J Weiss
Published 2016-01-01

Horizontal Combination of MEK and PI3K/mTOR Inhibition in BRAF Mutant Tumor Cells with or without Concomitant PI3K Pathway Mutations

by Dominika Rittler, Eszter Molnár, Marcell Baranyi, Tamás Garay, Luca Hegedűs, Clemens Aigner, József Tóvári, József Tímár, Balázs Hegedűs
Published 2020-10-01

Long-Term Vemurafenib Exposure Induced Alterations of Cell Phenotypes in Melanoma: Increased Cell Migration and Its Association with EGFR Expression

by Eszter Molnár, Tamás Garay, Marco Donia, Marcell Baranyi, Dominika Rittler, Walter Berger, József Tímár, Michael Grusch, Balázs Hegedűs
Published 2019-09-01

Histone Deacetylase Inhibitor Treatment Increases the Expression of the Plasma Membrane Ca2+ Pump PMCA4b and Inhibits the Migration of Melanoma Cells Independent of ERK

by Luca Hegedüs, Luca Hegedüs, Rita Padányi, Judit Molnár, Katalin Pászty, Karolina Varga, Karolina Varga, István Kenessey, Eszter Sárközy, Matthias Wolf, Michael Grusch, Zoltán Hegyi, László Homolya, Clemens Aigner, Tamás Garay, Balázs Hegedüs, Balázs Hegedüs, József Tímár, József Tímár, Enikö Kállay, Ágnes Enyedi, Ágnes Enyedi
Published 2017-05-01

Allosteric and ATP-Competitive MEK-Inhibition in a Novel Spitzoid Melanoma Model with a RAF- and Phosphorylation-Independent Mutation

by Luca Hegedüs, Özlem Okumus, Elisabeth Livingstone, Marcell Baranyi, Ildikó Kovács, Balázs Döme, József Tóvári, Ágnes Bánkfalvi, Dirk Schadendorf, Clemens Aigner, Balázs Hegedüs
Published 2021-02-01

Targeting an Oncolytic Influenza A Virus to Tumor Tissue by Elastase

by Irina Kuznetsova, Tobias Arnold, Thomas Aschacher, Cornelia Schwager, Balazs Hegedus, Tamas Garay, Marina Stukova, Maria Pisareva, Stephan Pleschka, Michael Bergmann, Andrej Egorov
Published 2017-12-01

Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells

by Eszter Molnár, Dominika Rittler, Marcell Baranyi, Michael Grusch, Walter Berger, Balázs Döme, József Tóvári, Clemens Aigner, József Tímár, Tamás Garay, Balázs Hegedűs
Published 2018-05-01

The Antitumor Effect of Lipophilic Bisphosphonate BPH1222 in Melanoma Models: The Role of the PI3K/Akt Pathway and the Small G Protein Rheb

by Dominika Rittler, Marcell Baranyi, Eszter Molnár, Tamás Garay, István Jalsovszky, Imre Károly Varga, Luca Hegedűs, Clemens Aigner, József Tóvári, József Tímár, Balázs Hegedűs
Published 2019-10-01

BARD1 serum autoantibodies for the detection of lung cancer.

by Maxim Pilyugin, Pascaline Descloux, Pierre-Alain André, Viktoria Laszlo, Balazs Dome, Balazs Hegedus, Sylvain Sardy, Samuel Janes, Andrea Bianco, Geoffrey J Laurent, Irmgard Irminger-Finger
Published 2017-01-01

Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases.

by Thomas Schweiger, Christoph Nikolowsky, Patrick Starlinger, Denise Traxler, Matthias Zimmermann, Peter Birner, Balazs Hegedüs, Balazs Dome, Michael Bergmann, Michael Mildner, Walter Klepetko, Konrad Hoetzenecker, Hendrik Jan Ankersmit
Published 2015-01-01

Prenylation inhibition-induced cell death in melanoma: reduced sensitivity in BRAF mutant/PTEN wild-type melanoma cells.

by Tamás Garay, István Kenessey, Eszter Molnár, Éva Juhász, Andrea Réti, Viktória László, Anita Rózsás, Judit Dobos, Balázs Döme, Walter Berger, Walter Klepetko, József Tóvári, József Tímár, Balázs Hegedűs
Published 2015-01-01

Neutrophil–lymphocyte ratio is prognostic in early stage resected small-cell lung cancer

by Zoltan Lohinai, Laura Bonanno, Aleksei Aksarin, Alberto Pavan, Zsolt Megyesfalvi, Balazs Santa, Virag Hollosi, Balazs Hegedus, Judit Moldvay, PierFranco Conte, Mikhail Ter-Ovanesov, Evgeniy Bilan, Balazs Dome, Glen J. Weiss
Published 2019-07-01

Erythropoietin receptor expression is a potential prognostic factor in human lung adenocarcinoma.

by Anita Rózsás, Judit Berta, Lívia Rojkó, László Z Horváth, Magdolna Keszthelyi, István Kenessey, Viktória László, Walter Berger, Michael Grusch, Mir Alireza Hoda, Szilvia Török, Walter Klepetko, Ferenc Rényi-Vámos, Balázs Hegedűs, Balázs Döme, József Tóvári
Published 2013-01-01

Screening of Pleural Mesothelioma Cell Lines for Kinase Activity May Identify New Mechanisms of Therapy Resistance in Patients Receiving Platin-Based Chemotherapy

by Sabrina Borchert, Pia-Maria Suckrau, Michael Wessolly, Elena Mairinger, Balazs Hegedus, Thomas Hager, Thomas Herold, Wildfried E. E. Eberhardt, Jeremias Wohlschlaeger, Clemens Aigner, Agnes Bankfalvi, Kurt Werner Schmid, Robert F. H. Walter, Fabian D. Mairinger
Published 2019-01-01

KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy

by Áron Kristof Ghimessy, Áron Gellert, Erzsebet Schlegl, Balazs Hegedus, Erzsebet Raso, Tamas Barbai, Jozsef Timar, Gyula Ostoros, Zsolt Megyesfalvi, Balazs Gieszer, Judit Moldvay, Ferenc Renyi-Vamos, Zoltan Lohinai, Mir Alireza Hoda, Thomas Klikovits, Walter Klepetko, Viktoria Laszlo, Balazs Dome
Published 2019-10-01